Creating More Hope and Possibility for Every Person With Breast Cancer
This year alone, more than 300,000 people in the United States will receive the life-altering news that they have breast cancer. And 1 in every 8 American women are likely to receive that diagnosis in their lifetime. For each of those people, a cure can’t come soon enough.
Right now, MSK has over 50 clinical trials enrolling people with breast cancer. We are constantly working toward developing the next leading-edge treatment options. Toward the next cure.
Each clinical trial, each new breakthrough, creates more hope and more possibilities for every person diagnosed with breast cancer. As a member of the MSK Giving community, you are part of the next breakthrough.
Accelerating Breast Cancer Breakthroughs Together
With the support of the MSK Giving community, MSK has made major breakthroughs in the last few years, including:
- The first targeted drug to treat HER2-low breast cancer, which created a new standard of care.
- Approval of a new breast cancer drug for certain people with advanced or metastatic breast cancer (stages 3 and 4).
- The discovery that AI might help radiologists identify invasive lobular carcinoma of the breast, a cancer that can be hard to diagnose due to its variable appearance.
Researchers at MSK are building upon these breakthroughs. But we can’t do it without your support. Thank you for funding groundbreaking research that could lead to tomorrow’s cures.